comparemela.com

Latest Breaking News On - Silji abraham - Page 15 : comparemela.com

West Pharmaceutical Services, Inc (NYSE:WST) SVP Sells $2,932,112 00 in Stock

West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) SVP Silji Abraham sold 8,020 shares of the business’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $365.60, for a total value of $2,932,112.00. Following the sale, the senior vice president now directly owns 4,209 shares of the […]

Silji Abraham Sells 8,020 Shares of West Pharmaceutical Services, Inc (NYSE:WST) Stock

West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) SVP Silji Abraham sold 8,020 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $365.60, for a total value of $2,932,112.00. Following the transaction, the senior vice president now owns 4,209 shares of […]

Davidson Capital Management Inc Acquires New Stake in West Pharmaceutical Services, Inc (NYSE:WST)

Davidson Capital Management Inc. bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 3,104 shares of the medical instruments supplier’s stock, valued at approximately $731,000. Other hedge […]

West Pharmaceutical Services (NYSE:WST) Releases FY 2023 Earnings Guidance

West Pharmaceutical Services (NYSE:WST – Get Rating) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $7.50-$7.65 for the period, compared to the consensus estimate of $7.42. The company issued revenue guidance of $2.96 billion-$2.99 billion, compared to the consensus revenue estimate of $2.96 billion. West Pharmaceutical […]

West Pharmaceutical Services (NYSE:WST) Issues FY 2023 Earnings Guidance

West Pharmaceutical Services (NYSE:WST – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $7.50-$7.65 for the period, compared to the consensus EPS estimate of $7.42. The company issued revenue guidance of $2.96 billion-$2.99 billion, compared to the consensus revenue estimate of $2.96 billion. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.